Press Releases

Month Year

Month Year

Oct 28, 2021

Insmed Ranks No. 1 on Science's 2021 Top Biopharma Employers List

Read more
Oct 28, 2021

Insmed Reports Third Quarter 2021 Financial Results and Provides Business Update

--ARIKAYCE® (amikacin liposome inhalation suspension) Now Launched in Three Major Territories; Positive Early Trends in Japan--

Read more
Oct 14, 2021

Insmed to Host Third Quarter 2021 Financial Results Conference Call on Thursday, October 28, 2021

Read more
Oct 5, 2021

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Read more
Sep 3, 2021

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Read more
Sep 1, 2021

Insmed To Participate in Five September Conferences

Read more
Aug 6, 2021

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Read more
Aug 5, 2021

Insmed Reports Second Quarter 2021 Financial Results and Provides Business Update

--ARIKAYCE® (amikacin liposome inhalation suspension) Now Launched in Japan; Available in Three Major Territories--

Read more
Jul 27, 2021

Insmed to Host Second Quarter 2021 Financial Results Conference Call on Thursday, August 5, 2021

Read more
Jul 8, 2021

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Read more

Show per page

Stay In The Loop

Want to stay up to date on our news, events, and filings? Set up your email alerts.

Investor Presentation

View the latest Insmed Investor Presentation